Libo Yan

1.3k total citations
54 papers, 961 citations indexed

About

Libo Yan is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Libo Yan has authored 54 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 15 papers in Molecular Biology and 14 papers in Hepatology. Recurrent topics in Libo Yan's work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis B Virus Studies (16 papers) and Hepatitis C virus research (12 papers). Libo Yan is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Hepatitis B Virus Studies (16 papers) and Hepatitis C virus research (12 papers). Libo Yan collaborates with scholars based in China, United States and Japan. Libo Yan's co-authors include Yan Xu, Qingchun Cai, Hong Tang, Qi Cai, Lingyao Du, Lang Bai, Hong Zhang, Erjie Tian, Yuxia Zhang and Jinghua Han and has published in prestigious journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Libo Yan

49 papers receiving 951 citations

Peers

Libo Yan
Comparison fields: 5 of 86
  • Molecular Biology 418
  • Epidemiology 376
  • Hepatology 182
  • Cell Biology 157
  • Oncology 119
Replace Pamela Hale with:
Pamela Hale United States
Denis Rousseau France
Ming Tang China
Peike Peng China
Klaus Fuchs Germany
Wannan Chen China
Insook Jang United States
Janet Owens‐Grillo United States
Chao Liang China
André Groyer France
Pamela Hale United States View profile →
Citations per field, relative to Libo Yan
Libo Yan · 1×
Citations per year, relative to Libo Yan
Libo Yan · 1×

Countries citing papers authored by Libo Yan

Since Specialization
Citations

This map shows the geographic impact of Libo Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Yan more than expected).

Fields of papers citing papers by Libo Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Yan. The network helps show where Libo Yan may publish in the future.

Co-authorship network of co-authors of Libo Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Libo Yan. A scholar is included among the top collaborators of Libo Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libo Yan. Libo Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 0
3 0
4 2
5 1
6 0
7 12
8 7
9 13
10 15
11 18
12
Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells
2
13 1
14 24
15
Hypoxic conditions differentially regulate TAZ and YAP in cancer cells
1
16 88
17 69
18 20
19 180
20 28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026